BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26665435)

  • 1. [Testing of apathogenic influenza virus H5N3 as a poultry live vaccine].
    Boravleva EY; Chvala IA; Lomakina NF; Repin PI; Mudrak NS; Rudenko LG; Gambaryan AS; Drygin VV
    Vopr Virusol; 2015; 60(4):44-9. PubMed ID: 26665435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
    Gambaryan AS; Lomakina NF; Boravleva EY; Kropotkina EA; Mashin VV; Krasilnikov IV; Klimov AI; Rudenko LG
    Influenza Other Respir Viruses; 2012 May; 6(3):188-95. PubMed ID: 21951678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The generation and characteristics of reassortant influenza A virus with H5 hemagglutinin and other genes from the apathogenic virus H6N2].
    Boravleva EIu; Lomakina NF; Kropotkina EA; Rudneva IA; Iamnikova SS; Rudenko LG; Drygin VV; Gambarian AS
    Vopr Virusol; 2011; 56(6):9-14. PubMed ID: 22359942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with live nonpathogenic H5N3 duck influenza virus protects chickens against highly pathogenic H5N1 virus.
    Gambaryan AS; Boravleva EY; Lomakina NF; Kropotkina EA; Gordeychuk IV; Chvala IA; Drygin VV; Klenk HD; Matrosovich MN
    Acta Virol; 2016; 60(3):316-27. PubMed ID: 27640442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
    Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
    Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
    Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
    Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of H5 hemagglutinin vaccine antigen in common duckweed (Lemna minor) protects against H5N1 high pathogenicity avian influenza virus challenge in immunized chickens.
    Bertran K; Thomas C; Guo X; Bublot M; Pritchard N; Regan JT; Cox KM; Gasdaska JR; Dickey LF; Kapczynski DR; Swayne DE
    Vaccine; 2015 Jul; 33(30):3456-62. PubMed ID: 26067184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a high-yield attenuated vaccine strain wholly derived from avian influenza viruses by use of reverse genetics.
    Liu M; Liu CG; Zhang Y; Shi WL; Wang W; Liu YY
    Vet Microbiol; 2012 Dec; 161(1-2):43-8. PubMed ID: 22832374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics.
    Liu M; Wood JM; Ellis T; Krauss S; Seiler P; Johnson C; Hoffmann E; Humberd J; Hulse D; Zhang Y; Webster RG; Perez DR
    Virology; 2003 Sep; 314(2):580-90. PubMed ID: 14554086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
    Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.
    Gao W; Soloff AC; Lu X; Montecalvo A; Nguyen DC; Matsuoka Y; Robbins PD; Swayne DE; Donis RO; Katz JM; Barratt-Boyes SM; Gambotto A
    J Virol; 2006 Feb; 80(4):1959-64. PubMed ID: 16439551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular delivery of HA1 subunit antigen through attenuated Salmonella Gallinarum act as a bivalent vaccine against fowl typhoid and low pathogenic H5N3 virus.
    Kamble NM; Hyoung KJ; Lee JH
    Vet Res; 2017 Aug; 48(1):40. PubMed ID: 28784184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of Domestic Ducks with Live Nonpathogenic H5N3 Influenza Virus Prevents Shedding and Transmission of Highly Pathogenic H5N1 Virus to Chickens.
    Gambaryan A; Gordeychuk I; Boravleva E; Lomakina N; Kropotkina E; Lunitsin A; Klenk HD; Matrosovich M
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29614716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of stockpiled vaccine against H5N8 highly pathogenic avian influenza virus isolated from a chicken in Kumamoto prefecture, Japan, in 2014.
    Gamoh K; Nakamizo M; Okamatsu M; Sakoda Y; Kida H; Suzuki S
    J Vet Med Sci; 2016 Jan; 78(1):139-42. PubMed ID: 26290130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.
    Song H; Nieto GR; Perez DR
    J Virol; 2007 Sep; 81(17):9238-48. PubMed ID: 17596317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.